visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

    Get Full Access

    Description

    • N30 Pharmaceuticals is now Nivalis Therapeutics, Inc.Cystic fibrosis (CF) is a multifaceted disease caused by dysfunction of the cystic fibrosistransmembrane conductance regulator (CFTR). The most common mutation, found in 90% of CF patients, is adeletion of phenylalanine at position 508 (F508delCFTR). The correctors currently in clinical developmenttargeting CFTR processing may be limited in effectively treating severe CF airways disease. Therefore, discoveryand development of more efficacious correctors of F508delCFTR continues to be a critically important goal of theCF community.
    • location

      Headquarters:3122 Sterling Cir Ste 200 , Boulder, Colorado, United States

      More
    • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. phone

      Phone Number: +1 303-440-0486

    • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. website

      Website:

    • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. employees

      Employees:5

    • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. revenue

      Revenue:$1 - 10M

    • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. legal name

      Legal Name:N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

    • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Social Media

      N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. linkedin N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. twitter
    • done Is this data correct?

    • |  NAICS Code: 424210  |

      Show More
    Person level website identification

    CEO for N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

    Jon Congleton

    President And Chief Executive Officer

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Vicki Abbas

    Director

    Frequently Asked Questions regarding N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

    • Where are N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Headquarters?

      N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Headquarters are in 3122 Sterling Cir Ste 200 ,Boulder,Colorado,United States

    • What is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s phone number?

      N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s phone number is +1 303-440-0486

    • What is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Revenue?

      N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s revenue is $1 - 10M

    • What is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s NAICS code?

      N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s NAICS code is 424210

    • How many employees are working in N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

      N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. has 5 employees

    • What is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Industry?

      N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. is in the industry of Biotechnology

    • Who is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s CEO?

      N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s CEO is Jon Congleton

    • Who is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Director?

      N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Director is Vicki Abbas

    Company Directory